Heterochromatin on the human inactive X chromosome
Heterochromatin on the human inactive X chromosome
批准号:
7921683
负责人:
Brian P. Chadwick
金额:
$31.29万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-02-01 至 2013-08-31
关键词:
Antisense RNABindingBinding SitesBiologicalBiological ModelsBiologyCCCTC-binding factorCell LineCell divisionCellsCentromereChemicalsChromatinChromatin FiberChromosomesChromosomes, Human, Pair 4CommunicationComplexCustomD4Z4DNADNA Methylation InhibitionDNA MethyltransferaseDNA Modification MethylasesDNA PackagingDNA SequenceDNA-Binding ProteinsDataDeoxyribonucleasesDiseaseDistalDrug FormulationsES Cell LineEmployee StrikesEnhancersEnsureEpigenetic ProcessEquilibriumEuchromatinExcisionFacioscapulohumeral Muscular DystrophyFamily memberFemaleFiber FISHFoundationsFunctional RNAFutureGene ExpressionGene SilencingGenesGenetic TranscriptionGenomeGenomicsGoalsHCT116 CellsHereditary DiseaseHeterochromatinHistone DeacetylationHistone H3HistonesHomologous GeneHumanIn VitroInsulator ElementsInterphaseInvestigationKnock-outLinkLocationLysineMaintenanceMalignant NeoplasmsMammalsMapsMediatingModelingModificationMolecularMonitorMusMutationNucleosomesNucleotidesPathway interactionsPatternPolycombPrimatesProcessProteinsRNARNA InterferenceRegulatory ElementReportingResearchResearch DesignResolutionRett SyndromeRoleSequence HomologySex ChromatinSideSignal TransductionSiteSmall RNASolidSomatic CellStructureSyndromeTestingTranscriptTranscriptional RegulationUrsidae FamilyVariantX ChromosomeX InactivationYin-Yangbasechemical geneticschromatin immunoprecipitationchromatin modificationchromatin proteindosageembryonic stem cellgenetic manipulationhistone methyltransferasehistone modificationimprintinsightmalemonomernovelpromoterpublic health relevancerecombinaseresearch studysexspatial relationshiptranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): X chromosome inactivation is an essential mammalian epigenetic process that serves to balance the levels of X-linked gene expression between the sexes. The inactive X chromosome (Xi) is the most extensive example of developmentally regulated gene silencing, and provides a model to explore in depth the epigenetic features of heterochromatin and to relate these to the underlying genomic DNA sequence. Unexpectedly, the X-linked macrosatellite DXZ4 is packaged into the opposite chromatin arrangement than that of the surrounding chromosome. Consequently, DXZ4 on the Xi is organized into euchromatin, whereas the array on the active X chromosome (Xa) is heterochromatic. DXZ4 is bi-directionally transcribed on both the Xa and Xi, but the processing of the non-coding RNAs differs between the two chromosomes. Cleavage of the antisense transcript into small RNAs coincides with the heterochromatic form of DXZ4, and the small RNAs themselves directly align with nucleosomes bearing the heterochromatin modification H3K9me3. Meanwhile, antisense RNA originating from the Xi is sufficiently stable that it can be detected as a longer transcript. Intriguingly, the chromatin insulator and epigenetic organizer protein CTCF binds specifically to the Xi array, immediately adjacent to the DXZ4 bi-directional promoter. To what extent CTCF is involved in establishing and maintaining DXZ4 chromatin on the Xi, and the impact this unusual organization has on flanking chromatin is unknown. However, the contrasting arrangement of DXZ4 chromatin between the X chromosomes and the specific binding of CTCF to the Xi is conserved at the functional homologue of DXZ4 on the mouse X chromosome (Dxz4), suggesting that this organization serves an important function. Our long-term goal is to understand the role of DXZ4 on the Xa and Xi and the extent to which it is involved in organizing and maintaining flanking chromatin and gene expression. We hypothesize that (A) The Xa processed antisense small RNAs are intimately linked to H3K9me3, via a mammalian pathway similar to RNAi mediated heterochromatin formation described for S.pombe, and (B) The Xi specific association of CTCF with DXZ4 ensures stabilization of antisense transcripts, packaging of the array into euchromatin and maintenance of flanking heterochromatin. In order to test these hypotheses, we propose three specific aims: (i) To define in detail the chromatin organization of DXZ4/Dxz4 on the Xa and Xi, (ii) To understand the role of DXZ4 features in maintaining chromatin and expression of both the array and flanking genomic interval on the Xa and Xi and (iii) To assess the role of Dxz4 on the mouse X. Taken together, these studies are designed to explore the mechanisms that direct packaging of DNA into euchromatin and heterochromatin and will provide valuable insight into the role of RNA in chromatin organization in complex genomes. As such, this research has direct relevance to all forms of epigenetic abnormalities including imprinting disorders, genetic disease involving mutation of chromatin proteins, and the many chromatin alterations observed in cancer. PUBLIC HEALTH RELEVANCE: The proposed studies aim to investigate an unusual epigenetic phenomena involving the macrosatellite sequence DXZ4 on the inactive X chromosome. DXZ4 is a paradigm to explore in depth the interplay between epigenetic features in establishing and maintaining chromatin organization. Therefore, this research has direct relevance to all forms of epigenetic abnormalities including imprinting disorders such as Prader-Willi/Angleman syndrome or Beckwith-Weidemann syndrome, genetic disease involving mutation of chromatin proteins such as Rett syndrome, and the many chromatin changes observed in cancer. Furthermore, understanding the packaging and organization of DXZ4 will have direct impact on Facioscapulohumeral Muscular Dystrophy research, a devastating macrosatellite contraction disorder.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exploring the contribution of large tandem repeat DNA to the organization and maintenance of the inactive X chromosome
-
批准号:9324288
-
项目类别:
-
资助金额:$28.58万
-
财政年份:2016
-
负责人:Brian P. Chadwick
-
依托单位:
Developing resources to alleviate muscle atrophy in FSHD by genome engineering
-
批准号:8414059
-
项目类别:
-
资助金额:$21.54万
-
财政年份:2012
-
负责人:Brian P. Chadwick
-
依托单位:
Developing resources to alleviate muscle atrophy in FSHD by genome engineering
-
批准号:8532067
-
项目类别:
-
资助金额:$17.16万
-
财政年份:2012
-
负责人:Brian P. Chadwick
-
依托单位:
Heterochromatin on the human inactive X chromosome
-
批准号:7008484
-
项目类别:
-
资助金额:$28.57万
-
财政年份:2005
-
负责人:Brian P. Chadwick
-
依托单位:
Heterochromatin on the human inactive X chromosome
-
批准号:7172232
-
项目类别:
-
资助金额:$27.74万
-
财政年份:2005
-
负责人:Brian P. Chadwick
-
依托单位:
Heterochromatin on the human inactive X chromosome
-
批准号:8512916
-
项目类别:
-
资助金额:$2.17万
-
财政年份:2005
-
负责人:Brian P. Chadwick
-
依托单位:
Heterochromatin on the human inactive X chromosome
-
批准号:6862191
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2005
-
负责人:Brian P. Chadwick
-
依托单位:
Heterochromatin on the human inactive X chromosome
-
批准号:7342441
-
项目类别:
-
资助金额:$27.74万
-
财政年份:2005
-
负责人:Brian P. Chadwick
-
依托单位:
Heterochromatin on the human inactive X chromosome
-
批准号:8327212
-
项目类别:
-
资助金额:$30.56万
-
财政年份:2005
-
负责人:Brian P. Chadwick
-
依托单位:
Heterochromatin on the human inactive X chromosome
-
批准号:8135311
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2005
-
负责人:Brian P. Chadwick
-
依托单位:
Heterochromatin on the human inactive X chromosome
-
批准号:7727688
-
项目类别:
-
资助金额:$30.84万
-
财政年份:2005
-
负责人:Brian P. Chadwick
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: